Breakthrough Innovations at CPHI Milan 2024
Thermo Fisher Scientific Inc., known as a leader in serving science, will showcase groundbreaking innovations that enhance the molecule-to-medicine journey. At the upcoming event, Thermo Fisher will engage with attendees at booth #7B18, discussing their impactful support for biotechnology and pharmaceutical companies throughout the entire drug development process.
Transforming Drug Development Processes
Michael Shafer, the executive vice president and president of biopharma services at Thermo Fisher Scientific, highlighted the company's commitment to transforming drug development and manufacturing. He noted that Thermo Fisher connects the vital steps of drug development—from early testing to clinical research design, trial conduct, and commercial scale-up—ensuring efficiency and innovative solutions at every stage.
Integrated Services for Drug Discovery
In an effort to streamline complexities in drug discovery and development, Thermo Fisher launched its Accelerator™ Drug Development program. This initiative represents a significant advancement in the pharmaceutical value chain, catering to both emerging and established companies. Through its contract development and manufacturing organization (CDMO) and contract research organization (CRO) solutions, Accelerator™ Drug Development offers customizable services—including research, manufacturing, and clinical supply chain support—to meet diverse customer needs.
Expanding Capabilities for Drug Development
Thermo Fisher is amplifying its efforts in pre-clinical drug development with enhanced facilities. The expansion includes new sites designed expressly for research, development, and manufacturing of oral solid dose formulations. Furthermore, the company is investing in its global clinical trial network, which features cutting-edge resources, such as a newly launched GMP-certified ultra-cold facility in the Netherlands, aimed at optimizing advanced therapies development.
Commitment to Sustainable Practices
As Thermo Fisher continues to evolve, sustainability remains a key focus. Recently, the company partnered with DHL Express to drive more sustainable clinical research services. This collaboration prioritizes reducing greenhouse gas emissions associated with air transportation logistics, aligning with the broader goal of enhancing environmental responsibility in the pharmaceutical sector.
Expert Sessions at CPHI Milan
During the CPHI Milan event, experts from Thermo Fisher will share insights on various subjects in live sessions scheduled for October 8 and 9. These sessions will cover essential topics such as navigating outsourcing partnerships and optimizing manufacturing processes—helping attendees gain a deeper understanding of current trends and strategies in the biopharmaceutical industry.
Enhancing Clinical Research Services
To bolster support for pharmaceutical and biotech customers, Thermo Fisher's PPD™ clinical research business is expanding its laboratory services globally. This includes the establishment of a new bioanalytical lab in Sweden to further accelerate health innovation and improve research capabilities.
About Thermo Fisher Scientific
With annual revenues exceeding $40 billion, Thermo Fisher Scientific stands as a prominent force in the scientific community. The company's mission is to enable its customers to enhance global health, safety, and environmental conditions. Thermo Fisher offers an unparalleled suite of innovative technologies and services, including widely recognized brands such as Thermo Scientific and Patheon.
Frequently Asked Questions
What is the significance of CPHI Milan for Thermo Fisher?
CPHI Milan serves as a platform for Thermo Fisher to showcase its innovative solutions and engage with key stakeholders in the pharmaceutical industry.
What is the Accelerator™ Drug Development program?
Accelerator™ Drug Development is Thermo Fisher's initiative offering comprehensive CDMO and CRO solutions tailored for the pharmaceutical value chain.
How is Thermo Fisher addressing sustainability?
The company has partnered with DHL Express to reduce emissions from clinical research logistics, supporting a commitment to sustainable practices.
What new facilities has Thermo Fisher opened recently?
Thermo Fisher has opened a GMP-certified ultra-cold facility in the Netherlands and expanded its bioanalytical lab in Sweden to enhance clinical research capabilities.
Who will represent Thermo Fisher at CPHI Milan?
Thermo Fisher's experts, including leaders in the field, will participate in various expert sessions addressing current industry trends and strategies.
